Here, common to hPAECs and hPASMCs, we found that KCNK3 knockdown reduces the expression of SOD2, supporting the role of KCNK3 in promoting PAH via aberrant DNA methylation. This evidence concerns the gene KCNK3 and pulmonary arterial hypertension.